stockrow
Friday 6 November 2026
Export AZTR’s income statement to Excel — free account
Azitra, Inc.
AZTR Healthcare Biotechnology
Azitra, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $7,500.00, down 98.9% from fiscal 2023.
- EPS
- +85.3%
- Free cash flow
- −19.6%
Quarter to June 2026, against a year earlier
0.75
0.02
+2.74%
Follow AZTR
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | |
|---|---|---|---|---|---|
Piotroski F-Score |
— | 3 | 3 | — | — |
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 2.79 | 10.70 | 13.46 | 13.46 |
Altman Z-Score |
— | (14.66) | (16.00) | — | — |
Altman Z″-Score (non-manufacturers) |
— | (28.50) | (38.17) | (24.96) | (16.73) |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | 13.02 | (5.04) | (2.16) | — |
P/Operating CF |
— | (0.63) | (2.89) | (3.78) | (3.78) |
P/B ratio |
— | 0.28 | 2.52 | 0.00 | 0.00 |
Price to Tangible BV |
— | 0.30 | 2.72 | 0.00 | 0.00 |
EV/Sales |
— | (5.04) | 8.12 | 28.00 | 28.00 |
EV/EBITDA |
— | 0.29 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | 0.29 | (0.76) | (1.06) | (1.06) |
EV/FCF |
— | 0.28 | (0.73) | (1.02) | (1.02) |
Quick Ratio |
2.07 | 3.38 | 1.26 | 1.69 | 6.93 |
Current Ratio |
2.83 | 3.80 | 1.58 | 1.86 | 7.02 |
Net Debt/EBITDA |
0.20 | 0.45 | 0.27 | (0.34) | (2.92) |
Debt/Assets |
0.00% | 0.14% | 0.51% | 92.08% | 340.02% |
Debt/Equity |
0.00 | 0.00 | 0.01 | (0.18) | (1.35) |
Asset Turnover |
0.00 | 0.00 | 0.11 | 0.03 | 0.00 |
Operating CF/Net income |
1.02 | 1.14 | 0.58 | 0.62 | 0.69 |
Capex/Depreciation |
(0.40) | (0.43) | (0.41) | (0.81) | 0.00 |
Interest Coverage |
(1,442.99) | (900.42) | (44.43) | (37.53) | (243.31) |
| (230.65%) | (208.27%) | 75.80% | 43.37% | 0.00% | |
| (176.93%) | (143.78%) | (205.80%) | (154.87%) | 0.00% | |
ROIC |
(395.49%) | (595.10%) | (407.29%) | 0.00% | 0.00% |
Return on Tangible Assets |
(438.23%) | (198.99%) | (769.50%) | (487.14%) | (142.34%) |
Average Days of Receivables |
0.00 | 4,959.13 | 118.92 | 342.12 | 1,108.94 |
Research and Development Expense of Revenue |
0.00% | 62,978.67% | 531.08% | 2,147.15% | 4,891.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 83,590.67% | 655.00% | 1,281.58% | 3,515.09% |
Intangible Assets out of Total Assets |
0.06 | 0.03 | 0.04 | 0.03 | 0.07 |
Share Based Compensation of Revenue |
0.00% | 3,268.00% | 22.08% | 64.96% | 0.00% |
Graham Net Nets |
— | 2.20 | 0.05 | 0.42 | 0.42 |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (554.00%) | (155.77%) | (187.72%) | (187.72%) |
Free Cash Flow Yield |
— | (652.75%) | (104.59%) | (204.09%) | (204.09%) |
Revenue per Share |
0.00 | 0.13 | 196.00 | 568.00 | 0.01 |
Operating CF per Share |
(23.03) | (178.35) | (2,103.54) | (16,699.00) | (0.67) |
Capex per Share |
(0.38) | (6.64) | (90.94) | (673.60) | 0.00 |
Free Cash Flow per Share |
(23.40) | (184.99) | (2,194.49) | (17,372.60) | (0.67) |
Cash per Share |
4.24 | 79.77 | 513.14 | 6,985.40 | 0.67 |
Shareholders Equity per Share |
7.80 | 99.80 | 832.31 | (72,520.60) | (2.13) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
Book value per Share |
7.80 | 99.80 | 832.31 | (72,520.60) | (2.13) |
Free Cash Flow |
(11.41) | (10.56) | (7.68) | (8.69) | (8.07) |
Working Capital |
1.95 | 3.85 | 0.93 | 1.91 | 7.28 |
Capital Expenditures |
(0.18) | (0.38) | (0.32) | (0.34) | (0.65) |
Net Current Asset Value |
1.80 | 3.57 | 0.33 | (39.29) | (27.48) |
EV/EBIT |
— | 0.27 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 50.56 | 0.46 | 1.19 | 0.00 |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||
Depreciation/Fixed assets |
0.83 | 1.36 | 1.09 | 0.49 | 0.09 |
Cash ROIC |
(194.35%) | (102.92%) | (162.20%) | 33.19% | (47.55%) |
Accounts Receivable Turnover |
0.00 | 0.05 | 2.80 | 0.95 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 3,089.59 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 |
Average Receivables |
0.12 | 0.16 | 0.24 | 0.30 | — |
Average Payables |
0.44 | 0.69 | 0.84 | 0.75 | — |
Average Assets |
6.19 | 6.24 | 6.14 | 8.68 | — |
Average Common Equity |
4.75 | 4.31 | (16.67) | (31.01) | — |
Columns are period end dates · fundamentals updated 2 Nov 2026